Sarrah Strimel Bentley and her boyfriend, James, were walking their dog at sunset when she felt an itch under her armpit. She ...

The Tobias-Lechleiter Institute for Clinical Innovation will serve as a hub for "groundbreaking" disease detection and ...

Drugmaker Eli Lilly and Company has hired Sandy Rodriguez as SVP and chief communications officer, effective on June 9. Rodriguez will report to Jennifer Oleksiw, SVP and global chief customer officer ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

Eli Lilly is turning up the volume on gene therapy with a $1.3 billion partnership with Rznomics to tackle sensorineural ...

Rznomics Inc. scored a potential ₩1.9 trillion (US$1.35 billion) global license option agreement with Eli Lilly and Co. to codevelop a novel RNA editing gene therapy to treat hereditary hearing loss.

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) has announced a series of executive leadership transitions aimed at bolstering the company’s growth trajectory, particularly in the U.S. and ...

Subscribe here to receive future editions. Despite last week's investor jitters, Eli Lilly is far from losing its strong grip on the booming weight loss market. As part of the move, Caremark ...